Management of Sinus Bradycardia

Initial Evaluation and Reversible Causes

The American College of Cardiology and the American Heart Association recommend identifying and treating any reversible causes before considering permanent pacing interventions for sinus bradycardia, which is defined as a heart rate less than 60 beats per minute, though clinically significant bradycardia typically occurs at rates below 50 beats per minute with associated symptoms 1, 2, 3
Common reversible causes of sinus bradycardia include medications such as beta blockers, calcium channel blockers, digoxin, and antiarrhythmic drugs, which should be discontinued or reduced in dosage 1, 3
Hypothyroidism is a reversible cause of sinus bradycardia, and treatment with thyroxine (T4) replacement is recommended 1, 4
Metabolic abnormalities, such as severe systemic acidosis or hypokalemia, should be corrected to treat sinus bradycardia 1, 3
Elevated intracranial pressure, acute myocardial infarction, obstructive sleep apnea, and severe hypothermia are also reversible causes of sinus bradycardia 1, 3

Asymptomatic sinus bradycardia does not require treatment, especially in young individuals, athletes, or during sleep, according to the American Heart Association 5
Symptomatic sinus bradycardia, such as syncope, lightheadedness, fatigue, or dyspnea, may require permanent pacing to increase heart rate and improve symptoms, as recommended by the American College of Cardiology 4
Atropine 0.5-1 mg IV may be used to treat acute symptomatic bradycardia, especially vagally-mediated, to block vagal effects 6
For chronic symptomatic bradycardia, permanent pacing is indicated when symptoms directly correlate with bradycardia, and a trial of oral theophylline may be considered to increase heart rate and improve symptoms in selected patients 4

For symptomatic bradycardia due to necessary guideline-directed medical therapy with no alternative treatment, permanent pacing is recommended by the American College of Cardiology 4
Electrophysiological studies (EPS) for sinus node function are not recommended for asymptomatic patients, but may be considered when diagnosis remains uncertain after initial noninvasive evaluation or when patients are undergoing EPS for another indication, according to the American Heart Association 1, 2, 7